Literature DB >> 19393582

Has the US Cancer Centre model been 'successful'? Lessons for the European cancer community.

Richard Sullivan1.   

Abstract

The US model of Cancer Centres created by the National Cancer Act in 1971 has been one of the most tried and tested models of organised disease-specific scientific endeavors in the world. With many countries, particularly those in Europe now looking to develop the research arms of their National Cancer Control Programmes through the development of similar Cancer Centres the time is correct to consider the success and limitations of the US effort to date. Here we described the salient features of both US Cancer Centres and Networks, including their funding and evaluation with socio-political analysis on the learning points for Europe. In particular we highlight issues around sustainable funding, training and network development. New data highlighting deficiencies in the US model around prevention, health promotion, health inequalities in cancer outcomes, and clinical research provide key learning points and opportunities for the European model developed.

Entities:  

Mesh:

Year:  2009        PMID: 19393582      PMCID: PMC5527857          DOI: 10.1016/j.molonc.2009.03.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  12 in total

1.  Research and the National Cancer Program.

Authors:  F J Rauscher
Journal:  Science       Date:  1975-07-11       Impact factor: 47.728

2.  THE PUBLIC AND THE CANCER PROBLEM.

Authors:  J Ewing
Journal:  Science       Date:  1938-05-06       Impact factor: 47.728

3.  A look inside the National Cancer Institute budget process: implications for 2007 and beyond.

Authors:  John E Niederhuber
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 4.  Has the US Cancer Centre model been 'successful'? Lessons for the European cancer community.

Authors:  Richard Sullivan
Journal:  Mol Oncol       Date:  2009-04-01       Impact factor: 6.603

5.  Congress looks harder at cancer.

Authors:  N Wade
Journal:  Science       Date:  1976-01-30       Impact factor: 47.728

6.  Trends in the global funding and activity of cancer research.

Authors:  Seth Eckhouse; Grant Lewison; Richard Sullivan
Journal:  Mol Oncol       Date:  2008-03-27       Impact factor: 6.603

7.  Training and mobility: a priority for the Organisation of the European Cancer Institutes. How a national mobility initiative could enhance EU cooperation in cancer research contributing to the development of an European Research Area: the example of The Italian Comprehensive Cancer Centers' Network "Alleanza Contro il Cancro".

Authors:  Claudio Lombardo; Daniela Albanese; Filippo Belardelli; Francesca d'Alessandro; Mauro Giacomini; Tania Rondanina; Luigi G Spagnoli
Journal:  Tumori       Date:  2008 Mar-Apr

8.  A survey of public funding of cancer research in the European union.

Authors:  Seth Eckhouse; Richard Sullivan
Journal:  PLoS Med       Date:  2006-07-18       Impact factor: 11.069

9.  Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.

Authors:  Ulrik Ringborg; Dominique de Valeriola; Wim van Harten; Antonio Llombart Bosch; Claudio Lombardo; Kenneth Nilsson; Thierry Philip; Marco A Pierotti; Peter Riegman; Mahasti Saghatchian; Guy Storme; Thomas Tursz; Dirk Verellen
Journal:  Tumori       Date:  2008 Mar-Apr

10.  Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).

Authors:  Mahasti Saghatchian; Henk Hummel; Renée Otter; Dominique de Valeriola; Wim Van Harten; Angelo Paradiso; Bert Koot; Ulrik Ringborg; Thomas Tursz
Journal:  Tumori       Date:  2008 Mar-Apr
View more
  3 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

Review 2.  Has the US Cancer Centre model been 'successful'? Lessons for the European cancer community.

Authors:  Richard Sullivan
Journal:  Mol Oncol       Date:  2009-04-01       Impact factor: 6.603

3.  Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.

Authors:  Sebastian Kehrloesser; Simon Oberst; Willien Westerhuis; Astrid Wendler; Anke Wind; Harriët Blaauwgeers; Jean-Benoit Burrion; Péter Nagy; Gunnar Saeter; Eva Gustafsson; Paolo De Paoli; József Lovey; Claudio Lombardo; Thierry Philip; Dominique de Valeriola; Marjet Docter; Femke Boomsma; Mahasti Saghatchian; Marek Svoboda; Irene Philip; Francesco Monetti; Henk Hummel; Gordon McVie; Renée Otter; Wim van Harten
Journal:  Mol Oncol       Date:  2021-03-30       Impact factor: 6.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.